Dow Up 0.76% Nasdaq Up 0.69%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
190.29 Up 4.37(2.35%) Oct 24, 3:59PM EDT
|After Hours : 190.29 0.00 (0.00%) Oct 24, 4:57PM EDT
Prev Close:185.92
Open:185.50
Bid:190.00 x 100
Ask:N/A
1y Target Est:204.29
Beta:1.07
Next Earnings Date:N/A
Day's Range:185.01 - 190.85
52wk Range:113.14 - 190.85
Volume:1,812,764
Avg Vol (3m):1,198,670
Market Cap:37.64B
P/E (ttm):95.38
EPS (ttm):2.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALXNUp 2.35%37.64B
AMGNUp 0.01%111.86B
BAXUp 1.06%37.83B

Key Statistics

Forward P/E (1 yr):32.47
P/S (ttm):19.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.15
Quarterly EPS Est (Dec-14) :1.26
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback